Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0266966
Abstract: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poor prognosis. Emerging evidence suggests that epigenetic alterations play a crucial role in HCC, suggesting epigenetic inhibition as a promising therapeutic approach. Indeed, the… read more here.
Keywords: transcriptome profiling; treated hepg2; inhibitor treated; comprehensive transcriptome ... See more keywords
Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA-treated HepG2 cells
Sign Up to like & getrecommendations! Published in 2019 at "Molecular Medicine Reports"
DOI: 10.3892/mmr.2019.10139
Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and has high rates of morbidity and mortality worldwide. Daphnetin (DAP) possesses notable antioxidative, anti-inflammatory and anticoagulant activities; DAP is an… read more here.
Keywords: expression; hepg2 cells; dap; insulin resistance ... See more keywords